Immuno Concepts

Immuno Concepts

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Immuno Concepts is a privately held, commercial-stage diagnostics company focused on autoimmune disease testing, particularly for systemic rheumatic diseases like lupus. Its core innovation is the HEp-2000® substrate, a genetically improved cell line that offers superior sensitivity for detecting key autoantibodies, supported by over thirty publications. The company has expanded its portfolio to include FDA-cleared tests and offers automation solutions like the Image Navigator® automated microscope and AFT pipetting stations to streamline laboratory workflow. With a quality system certified to ISO 13485:2016, Immuno Concepts has built a reputation over four decades on product quality, customer education, and technological advancement in immunofluorescence testing.

Autoimmune Rheumatic Diseases

Technology Platform

Patented HEp-2000® cell substrate (genetically engineered for SS-A/Ro sensitivity) combined with automated immunofluorescence systems including the Image Navigator® automated microscope and AFT pipetting stations.

Opportunities

Growing awareness and diagnosis of autoimmune diseases drives demand for high-quality testing.
The shift towards lab automation creates an opportunity for its Image Navigator® system to address workflow inefficiencies.
FDA clearances for specific tests on its platform open the large U.S.
regulated clinical market.

Risk Factors

Competition from large diagnostic firms and a market trend towards high-throughput, random-access solid-phase assays over manual immunofluorescence.
Regulatory hurdles and pace of FDA clearances for new tests on its automated platform.
Dependency on the patented HEp-2000® technology as a primary differentiator.

Competitive Landscape

Operates in the specialized autoimmune diagnostics segment, competing with large diversified diagnostics companies (e.g., Thermo Fisher, Werfen/Inova, Bio-Rad) and other specialty suppliers. Differentiates primarily through the clinically validated performance of its HEp-2000® substrate and its integrated automation solution, rather than competing on price or breadth of menu.